Christine de la Loge

University Medical Center Hamburg-Eppendorf

H指数:22

被引数:2,622

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bimekizumab demonstrates sustained improvement in quality of life up to week 104 in patients across the full spectrum of axial spondyloarthritis: results from phase 3 studies

Bimekizumab在全程轴性脊柱关节炎患者中显示出持续至第104周的生活质量改善：来自III期研究的结果

RHEUMATOLOGY

IF4.4

2025-04-280

PRE

Sustained improvement in clinical outcomes and long-term safety of bimekizumab in patients across the spectrum of axial spondyloarthritis up to week 104: results from two phase 3 studies

贝美克单抗在轴性脊柱关节炎全谱患者中的临床结局和长期安全性持续改善，直至第104周：两项III期研究的结果

RHEUMATOLOGY

IF4.4

2025-04-280

PRE

Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies

JOURNAL OF RHEUMATOLOGY

IF3.4

2024-10-151

Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO (May 2023, 10.1007/s40120-023-00464-x)

NEUROLOGY AND THERAPY

IF4.8

2023-06-270

OAAI

Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) (vol 13, pg 315, 2023)

DERMATOLOGY AND THERAPY

IF4.2

2023-05-300

OAAI

Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO

NEUROLOGY AND THERAPY

IF4.8

2023-05-1112

OAAI

Cognitive and Behavioral Effects of Adjunctive Brivaracetam in Children and Adolescents with Focal Seizures: Final Data From an Open-label Follow-up Trial

NEUROLOGY

IF8.5

2023-04-250

PRE

Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)

DERMATOLOGY AND THERAPY

IF4.2

2022-12-138

OAAI

Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study

Bimekizumab在活动性强直性脊柱炎患者中的安全性和有效性: IIb期随机对照试验及其开放标签扩展研究的三年结果

ARTHRITIS & RHEUMATOLOGY

IF10.9

2022-11-0740

Validation of the Pediatric Narcolepsy Screening Questionnaire (PNSQ): A cross-sectional, observational study

SLEEP MEDICINE

IF3.4

2022-10-012

OAAI

METHODS FOR ANALYZING PATIENT-REPORTED OUTCOMES IN ONCOLOGY TRIALS

VALUE IN HEALTH

IF6

2016-11-010

OAAI

Understanding the Patient Perspective of Seizure Severity in Epilepsy: Development of a Conceptual Model

PATIENT-PATIENT CENTERED OUTCOMES RESEARCH

IF3.1

2016-03-225

PRE

Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies

EPILEPSIA

IF6.6

2015-12-1544

PREDICTORS OF POOR HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH EPILEPSY: INSIGHT FROM THE PATIENTSLIKEME® EPILEPSY COMMUNITY

VALUE IN HEALTH

IF6

2012-06-010

OAAI

THE PATIENTSLIKEME® EPILEPSY COMMUNITY: A UNIQUE INSIGHT INTO THE LIVES OF PATIENTS WITH EPILEPSY

VALUE IN HEALTH

IF6

2011-05-011

OAAI

CAN THE CHQ-PF50 BE USED TO MONITOR CHANGES IN BEHAVIORAL AND EMOTIONAL FUNCTIONING IN CHILDREN TREATED FOR EPILEPSY?

VALUE IN HEALTH

IF6

2008-11-010

OAAI

Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis

OSTEOPOROSIS INTERNATIONAL

IF5.4

2007-10-1155

PREAI

Patient-reported outcomes helped predict survival in multiple myeloma using partial least squares analysis

JOURNAL OF CLINICAL EPIDEMIOLOGY

IF5.2

2007-07-0134

PREAI

Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2005-02-01156

PREAI

Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders

QUALITY OF LIFE RESEARCH

IF2.7

2004-12-01300

PREAI

Christine de la Loge

个人简介

教育背景

工作经历

荣誉奖项

研究方向